Endocrinology · Long-acting basal insulin
Insulin Glargine
Dose
0.1–0.2 U/kg SC once daily; titrate by 2 U every 3 days to fasting glucose 4.4–7.2 mmol/L.
Use
Monitoring
Side effects
- • Hypoglycaemia
- • Weight gain
- • Lipohypertrophy
Related in WardRound
Diabetic Ketoacidosis (DKA)
Protocol · Insulin + fluids + K⁺
Hyperosmolar Hyperglycaemic State
Protocol · Slow fluid resuscitation
Acute Kidney Injury
Protocol · KDIGO staging
Hyperkalaemia
Protocol · K⁺ > 5.5 mmol/L
Hypoglycaemia
Protocol · BSL < 4 mmol/L
HHS Complications
Protocol · Slow correction to prevent oedema
Type 2 Diabetes Mellitus
Topic · Endocrinology
Hyperkalaemia
Topic · Emergency Medicine
Diabetic Ketoacidosis
Topic · Emergency Medicine
β-Blocker Overdose
Topic · Toxicology
Calcium Channel Blocker Overdose
Topic · Toxicology
Gestational Diabetes Mellitus
Topic · Obs/Gynae
Always confirm dose against your local formulary / BNF before prescribing.
